A new wearable device may offer a breakthrough in how we respond to sudden cardiac emergencies. Researchers have developed and tested a smart-technology wristband capable of detecting cardiac arrest with high accuracy, a development that could transform survival rates for events occurring outside of hospital settings. The findings, published today in the American Heart Association’s peer-reviewed journal Circulation: Arrhythmia and Electrophysiology, mark a significant step toward creating a reliable digital witness for those at risk of life-threatening heart rhythms.
Cardiac arrest remains a leading cause of death globally, and its survival often hinges on the speed at which intervention occurs. Many of these emergencies happen away from medical facilities, where there may be no witnesses to sound the alarm. This new study, known as the DETECT-1b trial, evaluated whether a medically certified wristband could bridge this gap by continuously monitoring vital signs and automatically alerting emergency services when the heart stops pumping blood effectively.
The research team, based at Radboud University Medical Center in the Netherlands, focused on 49 adult patients who were already undergoing routine medical procedures to address abnormal heart rhythms. During these controlled clinical sessions, doctors briefly induced life-threatening heart rhythms—specifically pulseless ventricular tachycardia (pVT) or ventricular fibrillation (VF)—to test the device’s sensitivity. The results showed that the algorithm-based wristband successfully detected these cardiac arrest events 92% of the time.
How the Digital Witness Technology Works
The wearable device utilizes a technique known as photoplethysmography, which employs light-based sensors to monitor changes in blood flow at the wrist. While similar technology is common in consumer-grade smartwatches, this study is notable for being the first to externally validate an algorithm specifically designed to identify the cessation of a heartbeat using patient data. By continuously tracking these metrics, the device aims to identify the “shockable” rhythms that can be corrected by an Automated External Defibrillator (AED).
According to the study, the device demonstrated high precision in a clinical setting, detecting 100% of ventricular fibrillation events and 90% of pulseless ventricular tachycardia cases. Perhaps most importantly for the future of wearable health tech, the device maintained a relatively low rate of false positives, recording only nine such instances over 125 hours of monitoring. This balance between sensitivity and specificity is a critical hurdle for any technology intended to trigger emergency services.
Study Performance Metrics
| Event Type | Detection Accuracy |
|---|---|
| Ventricular Fibrillation | 100% |
| Pulseless Ventricular Tachycardia | 90% |
| Overall Accuracy | 92% |
Bridging the Gap Between Research and Real-World Use
The implications for public health are substantial. Judith Bonnes, M.D., Ph.D., a cardiologist at Radboud University Medical Center and the study’s senior author, emphasized that the ultimate goal is to integrate these devices into existing emergency response infrastructures. “The goal is to connect the wristband to emergency dispatch centers and volunteer responder networks in the Netherlands so that nearby rescuers and ambulance services can be alerted immediately when cardiac arrest is detected,” Bonnes said.
While the initial results are promising, experts caution that the transition from a controlled clinical environment to the unpredictability of daily life is a complex challenge. Cameron Dezfulian, M.D., FAHA, chair of the American Heart Association’s Resuscitation Science Symposium Program Committee, noted that while the technology shows great potential, further research is essential. “What is more impressive than the ability of this technology to detect cardiac arrest is the fairly low frequency of false positives it detected,” Dezfulian said. He added that because pulseless electrical activity remains a common presentation in cardiac arrests, future iterations of the technology will need to account for a wider variety of cardiac event data.
The research team acknowledges that the study’s controlled setting is a limitation. Because the cardiac events were induced in a hospital environment, the sensors were not subject to the motion artifacts, environmental variables, or other daily stressors that could impact the device’s accuracy in the real world. Future studies are expected to evaluate how the algorithm performs during regular, non-clinical activity.
What This Means for Patients
For those living with known heart conditions, this technology represents a potential shift from passive monitoring to active safety intervention. By serving as an automated “digital witness,” the device could drastically reduce the time between a collapse and the arrival of professional medical help. As the project continues under the broader DETECT initiative, the researchers plan to refine the algorithm to ensure it remains both reliable and unobtrusive for daily wear.
This article is for informational purposes only and does not constitute medical advice. If you or a loved one are concerned about heart health or are at risk for cardiac events, please consult with a qualified healthcare professional. For more information on the warning signs of cardiac arrest and how to perform CPR or use an AED, visit the American Heart Association website.
Researchers are expected to conduct further validation studies to test the device’s reliability outside of clinical settings. As the technology moves through these developmental phases, regulatory bodies and health systems will likely monitor the data to determine when such devices might be cleared for consumer use. We invite you to share your thoughts on the future of wearable health technology in the comments below.
